期刊文献+

Sprague-Dawley大鼠外周血来源间充质干细胞的动员、分离培养及鉴定 被引量:5

Mobilization,Culture,Isolation and Identification of Mesenchymal Stem Cells from Peripheral Blood of Sprague-Dawley Rats
下载PDF
导出
摘要 目的:探讨Sprague—Dawley大鼠外周血来源间充质干细胞(mesenchymal stem cells,MSC)的动员、分离培养及鉴定方法,分析其表面标记和多向分化潜能,为运动创伤中的细胞治疗和组织工程产品培育提供新来源的、可以微创获得和自体细胞移植的种子细胞。方法:联合动员大鼠外周血MSC.采集腹主动脉外周血4ml。使用淋巴细胞分离液结合密度梯度离心方法分离外周血单核细胞,体外培养至第3代。于显微镜下观察其形态和生长状态。取第3代MSC,鉴定其表型并向成骨、成脂和成软骨诱导分化.以证明其干细胞的特性。结果:经淋巴分离液结合密度梯度离心方法分离培养的外周血单核细胞.3~5天可见少量长梭形细胞贴壁,7-9天见细胞成簇生长,并形成克隆集落。第3代细胞形态较均一.生长增殖良好;表达典型的MSC标记CD44和CD90,不表达造血干细胞标记CD34和CD45。成骨诱导21天后,茜素红和ALP染色阳性,有矿化结节形成。成脂诱导21天后,油红0染色阳性.细胞内有脂滴形成。细胞微团无血清成软骨诱导21天后。甲苯胺蓝染色阳性,细胞外有蛋白多糖分泌:免疫组织化学染色示,特异性软骨基质II型胶原表达阳性。结论:采用联合药物动员方法能促进干细胞向外周血释放,分离培养的外周血干细胞经鉴定为MSC,体外具备三系分化潜能,有望成为运动创伤中新的细胞治疗和组织工程产品培育的种子细胞来源。 Objective The purpose of this study was to explore the methods of mobilization, isolation, culture and identification of mesenchymal stem cells (MSC) in rat peripheral blood,in order to find a new source for seeding cells with minimally invasion for cell therapy and tissue engineering products culturing in the field of sports traumatology. Methods MSC in peripheral blood were mobilized by ad- ministration of combined drugs. Mononuclear cells in blood samples from the abdominal aorta were iso- lated by lymphocyte separation medium and density gradient centrifugation.then cultured in vitro to the third passage through microscopic observation of morphological characteristics and growth state. The phenotype of the third passage MSC was identified,and the differentiation capacity into bone,adipose and cartilage was confirmed. Results After 3-5 days culture in vitro, a few isolated cells in spindle shape adhered to the plastic walls. And after 7-9 days culture in vitro, cells cluster and colonies appeared. The third passage cells showed uniform morphology and good proliferation with expression of the typical sur- face markers of MSC,including CD44 and CD90,and without expression of surface markers of hematopoietic stem cells such as CD34 and CD45. After 21-day induction of bone formation,the ceils demonstrated positive staining for Alizarin red and ALP, and formation of mineralization nodes. Positive staining for Oil red O and for Tolridine blue,and immunohistochemical staining for type I! collagen con- firmed the formation of cartilage-specific extracellular aggrecans and type II collagen. Conclusion These methods for mobilization by administration of combined drugs could increase the release of stem cells from peripheral blood. MSC cuhured in vitro had eages. MSC derived from peripheral blood could and tissue engineering. multipotent capacity of differentiation along three 1in- be a potential source of seeding ceils for cell therapy
出处 《中国运动医学杂志》 CAS CSCD 北大核心 2012年第9期811-816,共6页 Chinese Journal of Sports Medicine
基金 国家自然科学基金(30471783) 国家教委重点博士点基金(20030001009) 北京市自然科学基金(7052046)资助
关键词 外周血MSC 动员 多向分化潜能 Sprague—Dawley大鼠 mesenchymal stem ceils,peripheral blood,mobilization,multipotent differentiation, Sprague-Dawley rats
  • 相关文献

参考文献28

  • 1Bianco P, Robey PG, Simmons PJ. Mesenchymal stem cells: revisiting history,concepts,and assays. Cell Stem Cell, 2008,2(4) :313-319.
  • 2Reddy BY,Xu DS,Hantash BM. Mesenchymal stem cells as immunomodulator therapies for immune-mediated systemic dermatoses. Stem Ceils Dev, 2012,21 (3) : 352-362.
  • 3Maijenburg MW,van der Schoot CE,Voermans C. Mesenchymal stromal cell migration:possibilities to improve cellular therapy. Stem Ceils Dev, 2012,21 (1):19-29.
  • 4Jung Y,Bauer G,Nolta JA. Concise review:Induced plufipotent stem cell-derived mesenchymal stem cells: progress toward safe clinical products. Stem Cells, 2012,30( 1 ) :42-47.
  • 5Jiang Y,Jahagirdar BN,Reinhardt RL,et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature, 2002,418(6893) :41-49.
  • 6Wu KH,Han ZC,Mo XM,et al. Cell delivery in cardiac regenerative therapy. Ageing Res Rev, 2012,11 (1):32-40.
  • 7Larsen S,Lewis ID. Potential therapeutic applications of mesenchymal stromal cells. Pathology, 2011,43 (6) : 592- 604.
  • 8Roemeling-Van RM, Weimar W, Hoogduijn MJ. Mesenchymal stem cells:application for solid-organ transplantation. Curr Opin Organ Transplant, 2012,17 ( 1 ) : 55-62.
  • 9Hauzeur JP, Gangji V. Phases 1-3 clinical trials using adult stem cells in osteonecrosis and nonunion fractures. Stem Cells Int,2010:410-170.
  • 10Bernardo ME,Pagliara D,Locatelli F. Mesenchymal stromal cell therapy:a revolution in Regenerative Medicine Bone Marrow Transplant,2012,47(2) : 164-171.

同被引文献48

  • 1张俐,周海兵,刘烈刚.活血化瘀汤影响骨折愈合早期一氧化氮合酶活性的作用机制探讨[J].中国骨伤,2005,18(2):93-96. 被引量:5
  • 2徐叔云,卞如濂.药理实验方法学[M].3版.北京:人民卫生出版社,2006:759.
  • 3张俐,杨宗宇.活血化瘀汤对大鼠骨折愈合过程中血清骨钙素和Ⅰ型胶原表达的影响[J].中国骨伤,2007,20(8):527-528. 被引量:14
  • 4MAIJENBURG MW,VAN DER SCHOOT CE, VOERMANS C. Mesenchymal stromal cell migration: possibilities to improve cellular therapy [ J ]. Stem Cells Dev, 2012,21 (1) :19 -29.
  • 5ROEMELING - VAN RM,WEIMAR W, HOOGDUIJN MJ. Mesenchymal stem cells : application for solid - organ trans- plantation[ J]. Curr Opin Organ Transplant,2012,17 ( 1 ) : 55 - 62.
  • 6ZHOU S, GREENBERGER JS, EPPERLY MW, et al. Age - related intrinsic changes in human bone - marrow - derived mesenchymal stem cells and their differentiation to osteoblasts [ J ]. Aging Cell,2008,7 ( 3 ) :335 - 343.
  • 7张金生,王阶.动员骨髓干细胞“自发”归巢对急性心肌梗死治疗作用及活血化瘀方药干预机制[D].中国中医科学院,2008.
  • 8Yang G, Rothrauff BB, Tuan RS. Tendon and ligament regeneration and repair: clinical relevance and developmental paradigm. Birth Defects Res C Embryo Today, 2013, 99(3): 203-222.
  • 9Phinney DG. Functional heterogeneity of mesenchymal stem cells: implications for cell therapy. J Cell Biochem, 2012,113(9): 2806- 2812.
  • 10Figueroa D, Espinosa M, Cairo R, et al. Anterior cruciate ligamentregeneration using mesenchymal stem cells and collagen type I scaffold in a rabbit model. Knee Surg Sports Traurnatol Arthrosc, 2014, 22(5): 1196-1202.

引证文献5

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部